Literature DB >> 23327236

Abortion in Sri Lanka: the double standard.

Ramya Kumar1.   

Abstract

In Sri Lanka, women do not have access to legal abortion except under life-saving circumstances. Clandestine abortion services are, however, available and quite accessible. Although safe specialist services are available to women who can afford them, others access services under unsafe and exploitative conditions. At the time of this writing, a draft bill that will legalize abortion in instances of rape, incest, and fetal abnormalities awaits approval, amid opposition. In this article, I explore the current push for legal reform as a solution to unsafe abortion. Although a welcome effort, this amendment alone will be insufficient to address the public health consequences of unsafe abortion in Sri Lanka because most women seek abortions for other reasons. Much broader legal and policy reform will be required.

Entities:  

Mesh:

Year:  2013        PMID: 23327236      PMCID: PMC3673519          DOI: 10.2105/AJPH.2012.301154

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  8 in total

Review 1.  Making abortions safe: a matter of good public health policy and practice.

Authors:  M Berer
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

Review 2.  Achieving Millennium Development Goals 4 and 5 in Sri Lanka.

Authors:  H Senanayake; M Goonewardene; A Ranatunga; R Hattotuwa; S Amarasekera; I Amarasinghe
Journal:  BJOG       Date:  2011-09       Impact factor: 6.531

3.  Knowledge, attitudes and practices regarding postpartum contraception among 100 mother-father pairs leaving a Sri Lankan maternity hospital after childbirth.

Authors:  Hemantha Senanayake; S A Seneviratne; Viraj Kariyawasam
Journal:  Ceylon Med J       Date:  2006-03

4.  National laws and unsafe abortion: the parameters of change.

Authors:  Marge Berer
Journal:  Reprod Health Matters       Date:  2004-11

5.  Knowledge, behaviour and attitudes on induced abortion and family planning among Sri Lankan women seeking termination of pregnancy.

Authors:  Jennifer Perera; Tharangi de Silva; Harshana Gange
Journal:  Ceylon Med J       Date:  2004-03

6.  Misoprostol and the politics of abortion in Sri Lanka.

Authors:  Ramya Kumar
Journal:  Reprod Health Matters       Date:  2012-12

7.  Induced abortion in Sri Lanka: who goes to providers for pregnancy termination?

Authors:  Deok Jin Ban; Jinhyun Kim; W Indralal De Silva
Journal:  J Biosoc Sci       Date:  2002-07

Review 8.  Implementation of legal abortion in Nepal: a model for rapid scale-up of high-quality care.

Authors:  Ghazaleh Samandari; Merrill Wolf; Indira Basnett; Alyson Hyman; Kathryn Andersen
Journal:  Reprod Health       Date:  2012-04-04       Impact factor: 3.223

  8 in total
  4 in total

1.  Service provider perceptions of the trend in severity of symptoms and complications in women admitted following an incomplete abortion.

Authors:  Athula Kaluarachchi; Sumithra Tissera; Achini C Jayatilleke; Suchira Suranga; Philip Guest; Karthik Srinivasan; Bela Ganatra
Journal:  J Family Med Prim Care       Date:  2018 Nov-Dec

2.  Narratives of women presenting with abortion complications in Southwestern Nigeria: A qualitative study.

Authors:  Agnes A Oyeniran; Folasade A Bello; Babawale Oluborode; Ibraheem Awowole; Olabisi M Loto; Theresa A Irinyenikan; Adetokunbo O Fabamwo; Lanre Olutayo; Bela Ganatra; Philip Guest; Bukola Fawole
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

3.  Proportion of unplanned pregnancies, their determinants and health outcomes of women delivering at a teaching hospital in Sri Lanka.

Authors:  Iddamalgoda Dissanayakage Jayani Chalindra Ranatunga; Kapila Jayaratne
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-05       Impact factor: 3.007

4.  Medical ethics: knowledge, attitude and practice among doctors in three teaching hospitals in Sri Lanka.

Authors:  A W I P Ranasinghe; Buddhika Fernando; Athula Sumathipala; Wasantha Gunathunga
Journal:  BMC Med Ethics       Date:  2020-08-05       Impact factor: 2.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.